Takeda Pharmaceuticals U.S.A. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Takeda Pharmaceuticals U.S.A.

Sort by

Viewing results 1‒25 of 4287

News in-depthCryptocurrencies
‘Starkly fraudulent’ Scottish scheme revealed in crypto laundering case
...Alba Group and S Developments did not respond to a request for comment. A lawyer for Burke did not provide any comment for publication....
March 26, 2024
Brazil
Brazil rolls out dengue vaccines as cases rise sharply
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
February 25, 2024
FT Live
FTWeekend Festival: U.S. edition
Where the Financial Times weekend paper comes to life
Saturday, 4 MayThe REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
LexElectric vehicles
EU carmakers’ strategic U-turns point them in the right direction Premium content
...Slowing growth of electric vehicle sales has caused a series of corporate U-turns. While sharp swerves are never fun, the change in direction is sensible....
February 1, 2024
South Africa
S Africa proposes ‘innovative’ medical tourism plan allowing use of rhino horn
...involves the use of plants for pharmaceuticals and cosmetics....
April 6, 2024
Biotech
Weight loss biotech plans IPO as demand builds for anti-obesity treatments
...If ARD-101’s phase 3 trial is successful, it would also bring to market by 2026 a treatment for Prader-Willi syndrome, which causes weight gain since sufferers never feel full....
March 29, 2024
Cryptocurrencies
We need to talk about Franklin Templeton
...It’s only barely enough for inclusion into the S&P 500....
January 19, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
AstraZeneca PLC
AstraZeneca shareholders approve CEO Soriot’s £18.7mn pay despite revolt
...Like many European pharmaceutical companies, it makes a large proportion of sales in the US....
April 11, 2024
News in-depthWeight Watchers International Inc
WeightWatchers faces an era when weight loss comes in a syringe
...Two weeks after losing its most prominent brand ambassador, the weight-loss group lost another fifth of its value on reports its lenders were preparing for debt talks after S&P cut its credit rating to a...
April 9, 2024
Cryptocurrencies
What is a FRAX? And other pressing questions
...This is notwithstanding that a large share of USDT’s reserves comprise short-term U.S. treasury bills and other U.S. dollar cash equivalents....
December 13, 2023
Letter
Letter: Andrew Tate and threats to our social contract
...Just look at the rising numbers of sexual assaults on university campuses, the Metropolitan Police WhatsApp groups, and the “Everyone’s Invited” website documenting rape and sexual assault in...
March 12, 2024
LexHelen Thomas
The Lex Newsletter: Living in an Ozempic world Premium content
...The US pharmaceutical company — whose shares are up 130 per cent over the past year and is now a top-10 S&P 500 stock — chose the week of the Oscars to launch an advert called “Big Night”....
March 15, 2024
Disease control and prevention
First mass malaria vaccination campaign begins in Africa
...Children in Cameroon will begin receiving malaria vaccines as part of a rollout of the medicine developed by UK pharmaceutical company GSK in up to 12 countries across sub-Saharan Africa....
January 22, 2024
News in-depthEU economy
Ireland seeks to lure life science investment despite corporate tax rise
...Japanese drugmaker Takeda made its first investment in Ireland a quarter of a century ago when corporate tax was 10 per cent....
August 27, 2023
LexEli Lilly & Co
Eli Lilly’s heavyweight status looks set to last Premium content
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
January 16, 2024
Pharmaceuticals sector
Novo Nordisk and Eli Lilly hoover up smaller obesity drug groups
...Until this year, the biggest obesity deal was worth up to $185mn, when Japan’s Takeda Pharmaceuticals sold the US rights to the weight loss drug Contrave to California-based Orexigen Therapeutics in 2016...
October 24, 2023
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
High yield bonds
Is it PIK-up time for cash-strapped companies?
...Sure, a CCC-rated PIK bond looks better than a defaulted bond in your portfolio. But, as S&P puts it when explaining why U.S....
February 21, 2024
The FT ViewThe editorial board
The worrying return of a nasty virus
...If Covid-19’s reproduction or R number — the expected number of people one infected person will infect in a susceptible population — is 1-2, for measles it is 12-18....
January 28, 2024
News updates from January 31: Federal Reserve holds interest rates, EU commits €21bn in Ukraine military aid
Novartis boosts sales by 10% as heart and arthritis medicines help beat guidance
...Novartis notched a 10 per cent increase in sales in 2023 as strong performance for its heart and arthritis medicines helped Europe’s second-largest pharmaceuticals company beat its guidance for the year....
January 31, 2024
Biotech
US biotech fundraising boom ends 2-year deal drought
...The closely followed SPDR S&P Biotech ETF tumbled almost two-thirds from its 2021 high, weighed down by rising interest rates and a backlash to pandemic-era over-optimism about new drugs....
February 12, 2024
AstraZeneca PLC
AstraZeneca wrongfully dismissed senior scientist, tribunal finds
...The tribunal ruled that the largest company in the FTSE 100 discriminated against James Muir — a leading scientist who had been developing the pharmaceutical company’s drug, Truqap — on the basis of a disability...
January 31, 2024
US equities
Biotech stocks undergo recovery after year of ‘wreckage’
...Large drugmakers have also underperformed, with the S&P 500 pharmaceutical sub-index heading for its worst performance relative to the broader S&P 500 in at least 20 years....
December 14, 2023
Biotech
Japan’s development bank makes first UK life sciences investment
...The S&P biotech index is trading about 50 per cent below its peak in February 2021....
January 4, 2024
LexMergers & Acquisitions
Eli Lilly: Point acquisition gives battered biotech sector a boost Premium content
...A once-popular fund, the SPDR S&P Biotech ETF, has lost 14 per cent of its value this year, falling 60 per cent from its highs....
October 3, 2023
UK business
Barclays boss calls for UK economic development agency
...The intervention by Venkatakrishnan, boss of one of the UK’s biggest banks, comes after years of patchy relations between ministers and industry and frustration in boardrooms over policy U-turns by successive...
January 16, 2024
Equities
Equities rally takes FT stock pickers by surprise
...Commiserations to 2022’s winner Tyler Yarnell, who in 2023 came third last with a portfolio betting on Canadian oil companies — and a short position on Carvana....
January 12, 2024

Previous pagePage 1 of 172Next page